The somatostatin analogs market size is expected to see strong growth in the next few years. It will grow to $8.67 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to continued rise in net incidence, research focus on rare diseases, development of combination therapies, advancements in personalized medicine, global health initiatives in cancer care. Major trends in the forecast period include global aging population, healthcare infrastructure development in emerging markets, strategic collaborations and partnerships, pricing pressures and reimbursement challenges, technological integration in healthcare.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/somatostatin-analogs-global-market-report
Segmentation & Regional Insights
The somatostatin analogs market covered in this report is segmented –
1) By Type: Octreotide, Lanreotide, Pasireotide
2) By Treatment: Acromegaly, Cushing’s Syndrome, Neuroendocrine Tumors, Carcinoid Syndrome, Other Treatments
3) By End User: Hospital, Pharmaceutical Companies
North America was the largest region in the global somatostatin analogs treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatostatin analogs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10840&type=smp
Major Driver Impacting Market Growth
The rise in the incidence of neuroendocrine tumors is expected to propel the growth of the somatostatin analogs market going forward. Neuroendocrine tumors refer to malignancies that start in specialized neuroendocrine cells. Analogs of somatostatin prevent the body from producing too many hormones. They decrease a neuroendocrine tumor’s growth and reduce carcinoid disease symptoms. For instance, according to Cancer Australia, an Australia-based national government agency, in 2022, around 5,437 new cases of neuroendocrine tumors were diagnosed in Australia, and it was estimated that a person has a 1 in 55 risks of being diagnosed with neuroendocrine tumors by the age of 85. Therefore, the rise in the incidence of neuroendocrine tumors is driving the growth of the somatostatin analogs market.
Key Industry Players
Major companies operating in the somatostatin analogs market report are Novartis International AG, Pfizer Inc., Sun Pharmaceutical Industries Limited, Midatech Pharma plc, Crinetics Pharmaceuticals Inc., Peptron Inc., Teva Pharmaceutical Industries Ltd., Camurus AB, Dauntless Pharmaceuticals Inc., Bayer Aktiengesellschaft, Mylan N.V., Cadila Healthcare Limited, Amneal Pharmaceuticals Inc., Recordati S.p.A., Amryt Pharma plc, Ipsen Pharma SA, Fresenius Kabi AG, Biodexa Pharmaceuticals PLC, Chiasma Inc., Merck KGaA, Sanofi S.A., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc., Viatris Inc., AstraZeneca plc, Johnson & Johnson, Moderna Inc., HRA Pharma, Genentech Inc., OctreoPharm Sciences GmbH
The somatostatin analogs market report table of contents includes:
1. Executive Summary
2. Somatostatin Analogs Market Characteristics
3. Somatostatin Analogs Market Trends And Strategies
4. Somatostatin Analogs Market – Macro Economic Scenario
5. Global Somatostatin Analogs Market Size and Growth
……………………….
31. Global Somatostatin Analogs Market Competitive Benchmarking
32. Global Somatostatin Analogs Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Somatostatin Analogs Market
34. Somatostatin Analogs Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
https://goodprnews.com/pet-dental-health-global-market-size/
https://goodprnews.com/poc-medical-imaging-global-market-size/
https://goodprnews.com/proteinase-k-global-market-size/
https://topprnews.com/pet-dental-health-global-market-share/
https://topprnews.com/poc-medical-imaging-global-market-share/
https://topprnews.com/proteinase-k-global-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Foldable electric scooters are compact and portable personal transportation scooters equipped with…
Overview and Scope Flexible hybrid electronics (FHE) refer to electronic devices fabricated on flexible substrates,…
Overview and Scope Flexible electronics and circuits refer to electronic devices and circuits that can…
Overview and Scope A flat panel display refers to a type of electronic display device…
Overview and Scope Fixed-mobile convergence (FMC) refers to a telecommunications strategy that is designed to…
Overview and Scope Acrylic water-based paints refer to a type of paint composed of acrylic…